Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease

Clinical trial NCT05042206 · COMPLETED

Trial details

NCT number: NCT05042206
Sponsor: Pharmicell Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Kidney Disease Stage 3B Chronic Kidney Disease stage4

Start date: 2021-11-24
Primary completion: 2023-09-21
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.